[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576983":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":35,"responsibleParty":55,"collaborators":40,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":40,"enrollmentInfo":66,"targetDuration":40,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":38,"whyStopped":40,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"patients with drug-resistant focal epilepsy","EXPERIMENTAL","patients with drug-resistant focal epilepsy eligible for epilepsy surgery who will undergo the procedure immediately.",[13],"Diagnostic Test: quality of life",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","quality of life","The following assessment tools will be proposed to patients:\n\n* Quality of Life in Epilepsy (QOLIE-31)26\n* Dissociative Experience Scale (DES)27\n* Symptom Checklist-90 (SCL-90)28\n* Irritability Questionnaire (I-EPI)29\n* Beck Depression Inventory II (BDI-II)30\n* State-Trait Anxiety Inventory Y-1 e Y-2 (STAI)31\n* Epilepsy Stigma Scale modificata32 These assessment tools are validated and used universally, and will allow the collection of information on the psychological and psychiatric functioning of the patients.",[9],[21],"psychiatric symptoms",[23],{"name":24,"affiliation":25,"role":26},"Marco de Curtis, MD","Clinical and Experimental Epileptology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via G. Celoria 11, 20133 Milano, Italy","PRINCIPAL_INVESTIGATOR",[28,34],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Rui Quintas, PsyD","CONTACT","+39 02 2394","2487","rui.quintas@istituto-besta.it",{"name":24,"role":30,"phone":31,"phoneExt":32,"email":33},[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Foundation IRCCS Carlo Besta Neurological Institute","RECRUITING","Milan",null,"20133","Italy","IT",{"type":45,"coordinates":46},"Point",[47,48],12.59836,42.78235,{"lat":48,"lon":47},[51,53,54],{"name":29,"role":30,"phone":52,"phoneExt":32,"email":33},"02 2394",{"name":24,"role":30,"phone":31,"phoneExt":32,"email":33},{"name":29,"role":26,"phone":40,"phoneExt":40,"email":40},{"type":56,"investigatorFullName":40,"investigatorTitle":40,"investigatorAffiliation":40,"oldNameTitle":40,"oldOrganization":40},"SPONSOR","100576983","psychological-and-psychiatric-assessment-in-patients-eligible-for-epilepsy-surgery-100576983",false,"NCT06792383","Psychological and Psychiatric Assessment in Patients Eligible for Epilepsy Surgery","PsychoSurgery","Inclusion Criteria:\n\n* Patients aged 18 or older at the time of enrollment;\n* Patients with drug-resistant focal epilepsy followed at the Institute for at least 6 months;\n* Patients with drug-resistant focal epilepsy eligible for epilepsy surgery;\n* Patients capable of providing informed consent to participate in the study and for the processing of personal data.\n\nExclusion Criteria:\n\n* Patients with evident and\u002For diagnosed cognitive or psychiatric disorders that prevent participation in an interview, proper understanding of informed consent, or completion of questionnaires.","ALL","18 Years",{"count":67,"type":68},180,"ESTIMATED","INTERVENTIONAL",[71],"NA","The aim of the study is to describe the socio-demographic, clinical, psychological, and psychiatric characteristics of patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes in these parameters over time after surgery. Additionally, the study seeks to describe the levels of quality of life, dissociative experiences, prevalence of various psychiatric symptoms, irritability, depressive symptoms, anxiety symptoms, and stigma perception in patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes over time after surgery.",[74],"Focal Epilepsy With and Without Secondary Generalization",[76,17,21,77],"epilepsy","stigma","2026-02-10",{"date":80,"type":81},"2026-02-12","ACTUAL",{"date":83,"type":81},"2020-12-02",{"date":85,"type":68},"2026-12",{"name":5,"class":6},1]